Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 5, 2019
Patent Application Number
16002363
Date Filed
June 7, 2018
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
